ATE325812T1 - Menschliches, gebärmutterkrebs-spezifisches suppressorprotein, für das protein kodieres polynukleotid, mit dem polynukleotid transformierte zelle und verfahren zur unterdrückung der proliferation von krebszellen unter verwendung des expressionsvektors - Google Patents

Menschliches, gebärmutterkrebs-spezifisches suppressorprotein, für das protein kodieres polynukleotid, mit dem polynukleotid transformierte zelle und verfahren zur unterdrückung der proliferation von krebszellen unter verwendung des expressionsvektors

Info

Publication number
ATE325812T1
ATE325812T1 AT00983508T AT00983508T ATE325812T1 AT E325812 T1 ATE325812 T1 AT E325812T1 AT 00983508 T AT00983508 T AT 00983508T AT 00983508 T AT00983508 T AT 00983508T AT E325812 T1 ATE325812 T1 AT E325812T1
Authority
AT
Austria
Prior art keywords
polynucleotide
protein
expression vector
cancer
suppressor protein
Prior art date
Application number
AT00983508T
Other languages
English (en)
Inventor
Jin Woo Kim
Original Assignee
Jin Woo Kim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jin Woo Kim filed Critical Jin Woo Kim
Application granted granted Critical
Publication of ATE325812T1 publication Critical patent/ATE325812T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT00983508T 2000-04-25 2000-12-04 Menschliches, gebärmutterkrebs-spezifisches suppressorprotein, für das protein kodieres polynukleotid, mit dem polynukleotid transformierte zelle und verfahren zur unterdrückung der proliferation von krebszellen unter verwendung des expressionsvektors ATE325812T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2000-0021897A KR100426455B1 (ko) 2000-04-25 2000-04-25 인간 암 억제 유전자, 이에 의해 코딩되는 단백질, 이를포함하는 발현 벡터 및 이 벡터로 형질전환된 세포

Publications (1)

Publication Number Publication Date
ATE325812T1 true ATE325812T1 (de) 2006-06-15

Family

ID=36251014

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00983508T ATE325812T1 (de) 2000-04-25 2000-12-04 Menschliches, gebärmutterkrebs-spezifisches suppressorprotein, für das protein kodieres polynukleotid, mit dem polynukleotid transformierte zelle und verfahren zur unterdrückung der proliferation von krebszellen unter verwendung des expressionsvektors

Country Status (10)

Country Link
US (1) US6977296B2 (de)
EP (1) EP1282641B1 (de)
JP (1) JP3749182B2 (de)
KR (1) KR100426455B1 (de)
CN (1) CN1216909C (de)
AT (1) ATE325812T1 (de)
AU (1) AU2001220255A1 (de)
CA (1) CA2405983A1 (de)
DE (1) DE60027928T2 (de)
WO (1) WO2001081387A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100426452B1 (ko) * 2001-01-02 2004-04-13 김진우 인간 원암 유전자로 형질전환된 포유동물 및 이 유전자를이용한 유방암, 신장암, 난소암 또는 위암 진단용 키트
JP4070611B2 (ja) * 2001-04-23 2008-04-02 アマクサ アーゲー 電気穿孔法用の緩衝溶液およびその使用を含む方法
KR100434591B1 (ko) * 2002-04-16 2004-06-04 김진우 인간 암 억제 유전자, 이에 의해 코딩되는 단백질, 이를포함하는 발현 벡터 및 이 벡터로 형질전환된 세포
KR100664589B1 (ko) * 2004-12-28 2007-01-04 김현기 인간 암 억제 유전자, 이에 의해 코딩되는 단백질, 및이를 포함하는 발현 벡터
CN105061580B (zh) * 2006-10-03 2020-06-05 罗格斯新泽西州立大学 多肽和药物组合物及其应用
KR101815322B1 (ko) * 2010-01-12 2018-01-05 서울대학교산학협력단 항암 펩타이드 서열

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960034413A (ko) * 1995-03-24 1996-10-22 권계홍 아폽토시스 조절 유전자
JP2000510326A (ja) * 1996-02-14 2000-08-15 ノバルティス アクチエンゲゼルシャフト 移植および炎症状態に対する抗アポトーシス性遺伝子療法
AU4089699A (en) * 1998-05-28 1999-12-13 Incyte Pharmaceuticals, Inc. Tumor suppressor
CA2296792A1 (en) * 1999-02-26 2000-08-26 Genset S.A. Expressed sequence tags and encoded human proteins

Also Published As

Publication number Publication date
KR100426455B1 (ko) 2004-04-13
CA2405983A1 (en) 2001-11-01
WO2001081387A1 (en) 2001-11-01
DE60027928D1 (de) 2006-06-14
JP2003534783A (ja) 2003-11-25
EP1282641A1 (de) 2003-02-12
US6977296B2 (en) 2005-12-20
KR20010097640A (ko) 2001-11-08
US20040086974A1 (en) 2004-05-06
CN1451016A (zh) 2003-10-22
CN1216909C (zh) 2005-08-31
EP1282641B1 (de) 2006-05-10
JP3749182B2 (ja) 2006-02-22
AU2001220255A1 (en) 2001-11-07
DE60027928T2 (de) 2007-01-04
EP1282641A4 (de) 2004-05-19
HK1060136A1 (en) 2004-07-30

Similar Documents

Publication Publication Date Title
PT87562A (pt) Procede de expression de la proapolipoproteine a-i humaine
EP1548032A4 (de) Kdr-peptide und diese enthaltende impfstoffe
IL161591A (en) Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
DE69834267D1 (de) Gentherapeutische verfahren zur bereitstellung von apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dyslipidämischer erkrankungen
ATE329030T1 (de) Nukleinsäure, welche einen von lektin abstammenden faktor zur präservierung von progenitorzellen kodiert
MX2009008270A (es) Polipeptido novedoso que tiene actividad anti-tumoral.
ATE255635T1 (de) Polypeptid, fähig zur inhibierung der bindung zwischen menschliches il-6 und dessen rezeptor
NZ515964A (en) A method for the prophylaxis and/or treatment of medical disorders
CA2449284A1 (en) Alpha-fetoprotein peptides and uses thereof
DE69635349D1 (de) Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung
ATE536745T1 (de) Zusammensetzung mit arazym zur prävention und behandlung von krebs
BR9912279A (pt) Uso de uteroglobina humana recombinante no tratamento de condições inflamatórias e fibróticas
CA2386231A1 (en) Membrane translocating peptide drug delivery system
DE60027928D1 (de) MENSCHLICHES, GEBäRMUTTERKREBS-SPEZIFISCHES SUPPRESSORPROTEIN, FüR DAS PROTEIN KODIERES POLYNUKLEOTID, MIT DEM POLYNUKLEOTID TRANSFORMIERTE ZELLE UND VERFAHREN ZUR UNTERDRüCKUNG DER PROLIFERATION VON KREBSZELLEN UNTER VERWENDUNG DES EXPRESSIONSVEKTORS
ATE356145T1 (de) Polypeptide zur regenerierung des nervensystems
MX2024014754A (es) Metodos para inhibir el crecimiento del cancer
AU5327198A (en) Nucleotide sequence coding for a flavin-containing monooxygenase, corresponding protein and their applications in the fields of diagnosis and therapy
EA200100314A1 (ru) Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины
MX9806628A (es) Gen de respuesta de diferenciacion terminal mieloide humana novedoso.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties